GLIDAPAFLOZIN 10: Empowering Diabetes Management with Dapagliflozin (10mg)...

GLIDAPAFLOZIN 10 

Dapagliflozin (10mg)

GLIDAPAFLOZIN 10 represents a breakthrough in the treatment of type 2 diabetes mellitus, offering the therapeutic benefits of Dapagliflozin in its 10mg formulation. In this comprehensive guide, we delve into the intricacies of GLIDAPAFLOZIN 10, exploring its mechanism of action, therapeutic efficacy, dosage recommendations, potential side effects, and essential precautions, providing invaluable insights for patients and healthcare professionals alike.

Understanding Dapagliflozin (10mg): GLIDAPAFLOZIN 10 encapsulates Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor that acts by blocking the reabsorption of glucose in the kidneys, thereby promoting urinary excretion of glucose and lowering blood sugar levels in individuals with type 2 diabetes mellitus.

Mechanism of Action: Dapagliflozin inhibits SGLT2 receptors in the proximal renal tubules, preventing the reabsorption of glucose from the urine back into the bloodstream. By increasing urinary glucose excretion, Dapagliflozin helps reduce hyperglycemia and improve glycemic control in patients with type 2 diabetes mellitus.

Therapeutic Efficacy: Clinical studies have demonstrated the efficacy of GLIDAPAFLOZIN 10 in lowering HbA1c levels, reducing fasting blood glucose concentrations, and promoting weight loss in patients with type 2 diabetes mellitus. Additionally, Dapagliflozin has been shown to reduce the risk of cardiovascular events and progression of renal disease in high-risk individuals.

Dosage Recommendations: The recommended dosage of GLIDAPAFLOZIN 10 is typically 10mg once daily, administered orally with or without food. Healthcare providers may adjust the dosage based on individual patient response and tolerability. It is important for patients to adhere to the prescribed dosage regimen and to follow their healthcare provider's instructions closely.

Potential Side Effects: While generally well-tolerated, some patients may experience side effects such as urinary tract infections, genital mycotic infections, hypotension, or volume depletion with Dapagliflozin therapy. Rarely, more serious adverse reactions such as ketoacidosis or acute kidney injury may occur. Patients should be advised to promptly report any concerning symptoms to their healthcare provider for evaluation.

Precautions and Safety Measures: Before initiating GLIDAPAFLOZIN 10 therapy, healthcare providers should assess patients for factors that may predispose them to adverse events, such as a history of urinary tract infections, genital mycotic infections, or renal impairment. Close monitoring of renal function and electrolytes is recommended, particularly in patients with preexisting renal disease or those taking concomitant medications that may affect renal function.

Conclusion: GLIDAPAFLOZIN 10 offers a valuable addition to the armamentarium for the management of type 2 diabetes mellitus, providing patients with an effective and well-tolerated treatment option. Through its unique mechanism of action and demonstrated therapeutic efficacy, Dapagliflozin helps individuals achieve better glycemic control and reduce the risk of diabetes-related complications. With careful monitoring and patient education, GLIDAPAFLOZIN 10 continues to empower individuals with type 2 diabetes to lead healthier, more fulfilling lives. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW